These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22675142)

  • 1. Allopurinol desensitisation protocol for chronic untreated tophaceous gout.
    Abdelnabi M; Sanchez S; Chaisrimaneepan N; Mittal N
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514160
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic miliary gout complicated by chronic renal failure: a case report.
    Zhang X; Li Z; Zhou Y; Huang L
    Scand J Rheumatol; 2024 May; 53(3):233-235. PubMed ID: 38407204
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary oxypurinol is a useful tool to assess adherence to allopurinol in clinical practice.
    Hasikova L; Bartl J; Stiburkova B
    Rheumatology (Oxford); 2024 May; 63(6):e174-e176. PubMed ID: 38197578
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-B*5801 testing: Is it time to consider mandatory testing prior to prescribing allopurinol in Singapore?
    Ong FLL; Pang SM
    Ann Acad Med Singap; 2024 Mar; 53(3):211-212. PubMed ID: 38920247
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to allopurinol in patients with gout: further insights generate further questions.
    Robinson PC
    Lancet Rheumatol; 2020 May; 2(5):e249-e250. PubMed ID: 38273472
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing Gout in the Patient with Renal Impairment.
    Pascual E; Sivera F; Andrés M
    Drugs Aging; 2018 Apr; 35(4):263-273. PubMed ID: 29435850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol: insights from studies of dose-response relationships.
    Day RO; Kannangara DR; Stocker SL; Carland JE; Williams KM; Graham GG
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):449-462. PubMed ID: 27927043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of allopurinol in a patient on dialysis.
    Day RO; Kannangara DR; Hayes JM; Furlong TJ
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22675142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol and kidney function: An update.
    Stamp LK; Chapman PT; Palmer SC
    Joint Bone Spine; 2016 Jan; 83(1):19-24. PubMed ID: 26453097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol.
    Johnson WJ; O'Duffy JD
    Mayo Clin Proc; 1979 Sep; 54(9):618-20. PubMed ID: 470461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of naturally evolving gout in an elderly man.
    Bolzetta F; Veronese N; Mosele M; Sergi G; Manzato E; Giantin V
    Arch Gerontol Geriatr; 2012; 55(2):497-8. PubMed ID: 21944427
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.